Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
The Food and Drug Administration (FDA) is proposing to amend its classification regulations to designate class I devices that are exempt from the premarket notification requirements, subject to certain limitations, and to designate those class I devices that remain subject to premarket notification requirements under the new statutory criteria for premarket notification requirements. The devices FDA is proposing to designate as exempt do not include class I devices that have been previously exempted by regulation from the premarket notification requirements. This action is being taken under the Federal Food, Drug, and Cosmetic Act (the act), as amended by the Medical Device Amendments of 1976 (the 1976 amendments), the Safe Medical Devices Act of 1990 (SMDA), and the Food and Drug Administration Modernization Act of 1997 (FDAMA). FDA is taking this action in order to implement a requirement of FDAMA.
D000776:Anesthesiology / Q000295:instrumentation; D002624:Chemistry, Clinical / Q000295:instrumentation; D003762:Dental Instruments / Q000592:standards; D018795:Device Approval / Q000331:legislation & jurisprudence*; D004864:Equipment and Supplies / Q000009:adverse effects / Q000145:classification* / Q000592:standards; D006405:Hematology / Q000295:instrumentation; D007158:Immunologic Techniques / Q000295:instrumentation; D008828:Microbiological Techniques / Q000295:instrumentation; D010336:Pathology / Q000295:instrumentation; D014481:United States; D014486:United States Food and Drug Administration